| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL2300591 | 注射用RC108 | RC108 | Lyophilized | Biological Products(1) | New Drug Application | 2023-09-01 | RemeGen Co Ltd | view | |||
| CXSL2300197 | 注射用RC108 | RC108 | Lyophilized | Biological Products(1) | New Drug Application | 2023-03-16 | RemeGen Co Ltd | view | |||
| CXSL2300077 | 注射用RC108 | RC108 | Lyophilized | Biological Products(1) | New Drug Application | 2023-02-03 | RemeGen Co Ltd | view | |||
| CXSL2000262 | 注射用RC108 | RC108 | Lyophilized | Biological Products(1) | New Drug Application | 2020-09-10 | 荣昌生物制药（烟台）股份有限公司 | RemeGen Co Ltd | In Review | 2020-09-10 | view |